Minerva Neurosciences (NERV) Return on Capital Employed (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Minerva Neurosciences 215.11 Mn 215.11 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -559.00
Dec 31, 2025 3,022.00
Sep 30, 2025 51.00
Jun 30, 2025 215.00
Mar 31, 2025 108.00
Dec 31, 2024 232.00
Sep 30, 2024 -184.00
Jun 30, 2024 -1,124.00
Mar 31, 2024 -727.00
Dec 31, 2023 -678.00
Sep 30, 2023 104.00
Jun 30, 2023 937.00
Mar 31, 2023 58.00
Dec 31, 2022 2,403.00
Sep 30, 2022 -93.00
Jun 30, 2022 -319.00
Mar 31, 2022 -1,125.00
Dec 31, 2021 -2,186.00
Sep 30, 2021 -121.00
Jun 30, 2021 -3,872.00
Mar 31, 2021 495.00
Dec 31, 2020 4,168.00
Sep 30, 2020 1,045.00
Jun 30, 2020 5,982.00
Mar 31, 2020 -2,211.00
Dec 31, 2019 -3,261.00
Sep 30, 2019 -701.00
Jun 30, 2019 -370.00
Mar 31, 2019 -672.00
Dec 31, 2018 -526.00
Sep 30, 2018 -271.00
Jun 30, 2018 -328.00
Mar 31, 2018 -272.00
Dec 31, 2017 429.00
Sep 30, 2017 535.00
Jun 30, 2017 -512.00
Mar 31, 2017 -352.00
Dec 31, 2016 -190.00
Sep 30, 2016 155.00
Jun 30, 2016 1,102.00
Mar 31, 2016 -194.00
Dec 31, 2015 -376.00
Sep 30, 2015 2,103.00
Jun 30, 2015 2,235.00
Mar 31, 2015 943.00
Dec 31, 2014 106.00